<DOC>
	<DOCNO>NCT01640002</DOCNO>
	<brief_summary>It 's double blind , placebo control study ass efficacy Propantheline Bromide treat overactive bladder ( OAB ) HTLV 1 infect patient . We think treatment OAB Propantheline could reduce nocturia frequency sixty percent .</brief_summary>
	<brief_title>A Randomized , Placebo-Controlled Study Assess Efficacy Propantheline Treatment Overactive Bladder</brief_title>
	<detailed_description>Double blind , placebo control study ass efficacy Propantheline Bromide treat overactive bladder ( OAB ) HTLV 1 infect patient Treatment Group Propantheline Bromide : 15mg , three time daily 08 week . Control Group Placebo 03 time daily Case definition Clinically define OAB patient ( ICS criterion ) , infect HTLV-1 . Frequency define 08 daytime void . Nocturia define 02 void sleep . Inclusion criterion More 18 year . HTLV-1 infected patient overactive bladder . Negative culture urine . Without neurological impairment . Exclusion criterion Persistently positive urine culture History : Allergy medication , head spinal trauma . Head neck , neurological , spinal , low abdominal pelvic surgery . Stroke . Users urinary catheter .</detailed_description>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<mesh_term>Propantheline</mesh_term>
	<criteria>HTLV1 infection More 18 year Negative urine culture No neurological damage Diabetes Persistently positive urine culture Pelvic , head , urological gynecological surgery Stroke</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>overactive bladder</keyword>
	<keyword>HTLV-1</keyword>
	<keyword>Propantheline</keyword>
	<keyword>anticholinergic</keyword>
</DOC>